GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kidswell Bio Corp (TSE:4584) » Definitions » Debt-to-Revenue

Kidswell Bio (TSE:4584) Debt-to-Revenue : 0.58 (As of Dec. 2023)


View and export this data going back to 2012. Start your Free Trial

What is Kidswell Bio Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Kidswell Bio's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was 円550 Mil. Kidswell Bio's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was 円1,725 Mil. Kidswell Bio's annualized Revenue for the quarter that ended in Dec. 2023 was 円3,939 Mil. Kidswell Bio's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 0.58.


Kidswell Bio Debt-to-Revenue Historical Data

The historical data trend for Kidswell Bio's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kidswell Bio Debt-to-Revenue Chart

Kidswell Bio Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 1.14 1.10 0.45 0.70

Kidswell Bio Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.85 0.47 10.06 0.83 0.58

Competitive Comparison of Kidswell Bio's Debt-to-Revenue

For the Biotechnology subindustry, Kidswell Bio's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kidswell Bio's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kidswell Bio's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Kidswell Bio's Debt-to-Revenue falls into.



Kidswell Bio Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Kidswell Bio's Debt-to-Revenue for the fiscal year that ended in Mar. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(375 + 1575) / 2776.24
=0.70

Kidswell Bio's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(550 + 1725) / 3939.488
=0.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2023) Revenue data.


Kidswell Bio Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Kidswell Bio's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Kidswell Bio (TSE:4584) Business Description

Traded in Other Exchanges
N/A
Address
1-2-12, Shinkawa, Kanayama Building, 3rd Floor, Chuo-ku, Tokyo, JPN, 104-0033
Kidswell Bio Corp is a biopharmaceutical company engaged in the discovery and development of drugs.

Kidswell Bio (TSE:4584) Headlines

No Headlines